Showing results (41-50 of 542) with videos related to
Sort By:
Pageof 55
Neurodegenerative Disease Management|February 26, 2015
Remyelination in multiple sclerosis: what do we know and where are we going?Anna WilliamsNeurodegenerative Disease Management|February 26, 2015
The biomarker and therapeutic potential of miRNA in Alzheimer's diseaseLynn M Bekris, James B LeverenzNeurodegenerative Disease Management|August 4, 2020
Defining 'optimal' test cut-off using global test metrics: evidence from a cognitive screening instrumentAndrew J LarnerNeurodegenerative Disease Management|May 4, 2023
5-HT1A agonists for levodopa-induced dyskinesia in Parkinson's diseaseJawad Al-Kassmy, Christine Sun, Philippe HuotNeurodegenerative Disease Management|July 11, 2020
Safinamide in the treatment of Parkinson's diseaseThomas MüllerNeurodegenerative Disease Management|July 21, 2020
Diroximel fumarate in the treatment of multiple sclerosisElise Jonasson, Tobias SejbaekNeurodegenerative Disease Management|November 15, 2011
Using biomarkers to improve detection of Alzheimer's diseaseMilton C Biagioni, James E GalvinNeurodegenerative Disease Management|November 19, 2014
Treatment of cerebellar ataxiaTracy M Jones, Jessica D Shaw, Kelly Sullivan, et al.Neurodegenerative Disease Management|November 6, 2019
Amyloidosis: diagnosis and new therapies for a misunderstood and misdiagnosed diseaseVictoria E Thomas, Justin Smith, Merrill D Benson, et al.Neurodegenerative Disease Management|February 7, 2019
Valbenazine in the treatment of tardive dyskinesiaNatalie Witek, Cynthia ComellaPageof 55